0001609251-22-000003.txt : 20220517 0001609251-22-000003.hdr.sgml : 20220517 20220516205001 ACCESSION NUMBER: 0001609251-22-000003 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220331 FILED AS OF DATE: 20220517 DATE AS OF CHANGE: 20220516 EFFECTIVENESS DATE: 20220517 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Krensavage Asset Management, LLC CENTRAL INDEX KEY: 0001609251 IRS NUMBER: 262520930 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16807 FILM NUMBER: 22931931 BUSINESS ADDRESS: STREET 1: 610 FIFTH AVENUE STREET 2: SUITE 301 CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: 212-888-1582 MAIL ADDRESS: STREET 1: 610 FIFTH AVENUE STREET 2: SUITE 301 CITY: NEW YORK STATE: NY ZIP: 10020 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001609251 XXXXXXXX 03-31-2022 03-31-2022 Krensavage Asset Management, LLC

610 FIFTH AVENUE SUITE 301 NEW YORK NY 10020

13F HOLDINGS REPORT 028-16807 N Paul J. Paolino 212-518-3193 /s/ Paul J. Paolino New York NY 05-16-2022 0 13 290135 false INFORMATION TABLE 2 Krensavage_13F_03312022.xml KRENSAVAGE 13F 03.31.2022 ALKERMES PLC COM G01767105 37471 1424204 SH SOLE 1424204 0 0 ASSEMBLY BIOSCIENCES INC COM 045396108 21 10100 SH SOLE 10100 0 0 BIOGEN INC COM 09062X103 23451 111353 SH SOLE 111353 0 0 CARDINAL HEALTH INC COM 14149Y108 748 13200 SH SOLE 13200 0 0 EAGLE PHARMACEUTICALS INC COM 269796108 5681 114787 SH SOLE 114787 0 0 ENANTA PHARMACEUTICALS INC COM 29251M106 39066 548828 SH SOLE 548828 0 0 EXELIXIS INC COM 30161Q104 34694 1530406 SH SOLE 1530406 0 0 KODIAK SCIENCES INC COM 50015M109 3479 450600 SH SOLE 450600 0 0 MCKESSON CORP COM 58155Q103 38011 124165 SH SOLE 124165 0 0 NEXTCURE INC COM 65343E108 149 30591 SH SOLE 30591 0 0 REGENERON PHARMACEUTICALS COM 75886F107 46710 66880 SH SOLE 66880 0 0 TARO PHARMACEUTICAL INDUS COM M8737E108 24483 565951 SH SOLE 565951 0 0 UNITED THERAPEUTICS CORP COM 91307C102 36171 201612 SH SOLE 201612 0 0